期刊文献+

Rapid quantification of the metabolite of valacyclovir hydrochloride in human plasma by liquid chromatography-tandem mass spectrometry

Rapid quantification of the metabolite of valacyclovir hydrochloride in human plasma by liquid chromatography-tandem mass spectrometry
暂未订购
导出
摘要 Objective To establish a rapid,sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of acyclovir (the metabolite of valacyclovir hydrochloride) in human plasma. Methods After addition of ganciclovir as internal standard (IS),plasma samples were prepared by one-step protein precipitation using acetonitrile as precipitant,followed by an isocratic elution with 0.1% formic acid solution-methanol (95∶5,v/v) on an Agilent ZORBAX SB-C18 (150mm×2.1mm i.d.,3.5μm) column. Detection was performed on a triple-quadrupole mass spectrometer utilizing electrospray ionization (ESI) interface operating in positive ion and selected reaction monitoring (SRM) mode with the precursor to product ion transitions m/z 226.2→152.1 for acyclovir and m/z 256.2→152.1 for the IS. Results The analytical results demonstrated a good linearity over the ranges from 0.005 to 4μg/mL (r=0.9999) for valacyclovir hydrochloride. The relative standard deviations (RSD) of intra-batch and inter-batch were less than 4.06% and 9.23%,respectively. The limit of detection and lower limit of quantification in human plasma were 2ng/mL and 5ng/mL,respectively. Conclusion The method was simple,sensitive,accurate and reproducible and has been successfully applied to a bioequivalence study of valacyclovir hydrochloride capsules in Chinese healthy male volunteers. Objective To establish a rapid,sensitive and selective liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the determination of acyclovir (the metabolite of valacyclovir hydrochloride) in human plasma. Methods After addition of ganciclovir as internal standard (IS),plasma samples were prepared by one-step protein precipitation using acetonitrile as precipitant,followed by an isocratic elution with 0.1% formic acid solution-methanol (95∶5,v/v) on an Agilent ZORBAX SB-C18 (150mm×2.1mm i.d.,3.5μm) column. Detection was performed on a triple-quadrupole mass spectrometer utilizing electrospray ionization (ESI) interface operating in positive ion and selected reaction monitoring (SRM) mode with the precursor to product ion transitions m/z 226.2→152.1 for acyclovir and m/z 256.2→152.1 for the IS. Results The analytical results demonstrated a good linearity over the ranges from 0.005 to 4μg/mL (r=0.9999) for valacyclovir hydrochloride. The relative standard deviations (RSD) of intra-batch and inter-batch were less than 4.06% and 9.23%,respectively. The limit of detection and lower limit of quantification in human plasma were 2ng/mL and 5ng/mL,respectively. Conclusion The method was simple,sensitive,accurate and reproducible and has been successfully applied to a bioequivalence study of valacyclovir hydrochloride capsules in Chinese healthy male volunteers.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS 2010年第2期83-90,共8页 药物分析学报(英文版)
关键词 valacyclovir hydrochloride ACYCLOVIR liquid chromatography-tandem mass spectrometry method validation human plasma valacyclovir hydrochloride acyclovir liquid chromatography-tandem mass spectrometry method validation human plasma
  • 相关文献

参考文献10

  • 1Miserocchi E,Modorati G,Galli Let al.Efficacy of valacy- clovir vs acyclovir for the prevention of recurrent herpes si m- plex virus eye disease :a pilot study[].AmJ Ophthal mol.2007
  • 2Peyrire H,Branger B,Bengler Cet al.Neurotoxicity in- duced by Zelitrex (R) (valacyclovir) inthree patients withi m- paired renal function,overdose related to the i mprovement of the bioavailability of the drug[].Revue de Medecine Interne.2001
  • 3Bardin C,Hamel A,Pichard Aet al.Relation between con- centration and toxicity of the anti-herpesvirus drugs[].Phar macocintique des Mdicaments Anti-infectieux.2005
  • 4Zeng L,Nath CE,Shaw PJ et al.HPLC-fluorescence assay for acyclovir in children[].Biomedical Chromatography.2008
  • 5Yu LY,Xiang BR.Quantitative deter mination of acyclovir in plas ma by near infrared spectroscopy[].Microchemical Journal.2008
  • 6Sarva MT,Richard PQ,Devron RA.A competitive enzyme- linked i mmunosorbent assay to quantitate acyclovir and BW B759Uin human plas ma and urine[].Anti micro Agents Chemo- therapy.1986
  • 7Maes A,Garr B,Des met Net al.Deter mination of acyclo- vir in horse plas ma and body fluids by high-perfor manceliquid chromatography combined with fluorescence detection and heated electrospray ionization tandem mass spectrometry[].Bi- omed Chromatogr.2009
  • 8Ramakrishna NVS,Vishwottam KN,Koteshwara Met al.Rapid quantification of gabapentin in human plas ma by liquid chromatography/tandem mass spectrometry[].J Phar m Biomed Anal.2006
  • 9B. Garre,K. Shebany,A. Gryspeerdt,K. Baert,K. Meulen,H. Nauwynck,P. Deprez,P. Backer,S. Croubels.Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses[].Antimicrobial Agents and Chemotherapy.2007
  • 10Landowski,CP,Sun,D,Foster,DR.Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters[].Journal of Pharmacology and Experimental Therapeutics.2003

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部